Table 2.

Treatments, complications, and treatment outcomes of patients in the CDT and PMT groups.

	CDT group	PMT group	P value
Stenting	48 (45.3%)	15 (27.3%)	0.026∗
Thrombolysis duration (hours)	38.09 ± 14.20	24.56 ± 10.98	<0.001∗
rt-PA dosage (mg)	19.34 ± 5.93	13.55 ± 6.54	<0.001∗
Technical success	91 (85.9%)	54 (98.2%)	0.013∗
Length of hospital stay(days)	8.29 ± 3.91	5.49 ± 1.18	0.003∗
Composite clinical outcome	28 (26.4%)	5 (9.1%)	0.010∗
Death	21 (19.8%)	4 (7.3%)	0.037∗
Major amputation	4 (3.8%)	1 (1.8%)	0.498
Recurrent ischemia	2 (1.9%)	1 (1.8%)	0.976
Life-threatening hemorrhage	16 (15.1%)	2 (3.6%)	0.029∗
Vascular complication	2 (1.9%)	1 (1.8%)	0.976

Notes: CDT: catheter-directed thrombolysis; PMT: percutaneous mechanical thrombectomy; rt-PA: recombinant tissue plasminogen activator.